Farzaneh Darbeheshti, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
MicroRNAs | 8 | 2023 | 3750 | 0.940 |
Why?
|
Gene Regulatory Networks | 3 | 2021 | 1707 | 0.910 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2021 | 198 | 0.760 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2021 | 137 | 0.710 |
Why?
|
RNA, Untranslated | 1 | 2021 | 452 | 0.620 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2021 | 329 | 0.560 |
Why?
|
Chemokine CXCL12 | 1 | 2017 | 465 | 0.510 |
Why?
|
RNA, Messenger | 5 | 2023 | 13028 | 0.500 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2023 | 8430 | 0.470 |
Why?
|
Genetic Predisposition to Disease | 5 | 2022 | 17439 | 0.450 |
Why?
|
Communicable Diseases | 1 | 2021 | 880 | 0.420 |
Why?
|
Models, Genetic | 1 | 2020 | 3492 | 0.350 |
Why?
|
Influenza, Human | 1 | 2021 | 1480 | 0.350 |
Why?
|
DNA | 1 | 2022 | 7295 | 0.320 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9239 | 0.240 |
Why?
|
Melanoma | 1 | 2022 | 5508 | 0.220 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5691 | 0.210 |
Why?
|
Immunogenetics | 1 | 2022 | 67 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3134 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.200 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2022 | 437 | 0.180 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2021 | 165 | 0.180 |
Why?
|
Mannose-Binding Lectin | 1 | 2021 | 150 | 0.180 |
Why?
|
Genes, X-Linked | 1 | 2020 | 128 | 0.180 |
Why?
|
Orthomyxoviridae | 1 | 2021 | 156 | 0.170 |
Why?
|
Oligonucleotides | 1 | 2022 | 572 | 0.170 |
Why?
|
Signal Transduction | 2 | 2023 | 23398 | 0.170 |
Why?
|
Melanocytes | 1 | 2022 | 515 | 0.160 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 365 | 0.160 |
Why?
|
Toll-Like Receptors | 1 | 2021 | 593 | 0.150 |
Why?
|
BRCA2 Protein | 1 | 2022 | 794 | 0.150 |
Why?
|
Receptors, Virus | 1 | 2020 | 649 | 0.140 |
Why?
|
Molecular Sequence Annotation | 1 | 2019 | 528 | 0.140 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11708 | 0.140 |
Why?
|
BRCA1 Protein | 1 | 2022 | 1148 | 0.130 |
Why?
|
Computational Biology | 3 | 2022 | 3515 | 0.130 |
Why?
|
China | 1 | 2021 | 2243 | 0.130 |
Why?
|
Iran | 1 | 2017 | 709 | 0.120 |
Why?
|
ROC Curve | 1 | 2021 | 3527 | 0.120 |
Why?
|
Polymerase Chain Reaction | 1 | 2022 | 6170 | 0.110 |
Why?
|
Cell Proliferation | 3 | 2023 | 10477 | 0.110 |
Why?
|
Humans | 17 | 2023 | 743811 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2021 | 2453 | 0.100 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6773 | 0.100 |
Why?
|
Case-Control Studies | 2 | 2021 | 21733 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1580 | 0.100 |
Why?
|
Breast Neoplasms | 3 | 2023 | 20827 | 0.090 |
Why?
|
Gene Frequency | 1 | 2017 | 3585 | 0.090 |
Why?
|
Immunity, Innate | 1 | 2021 | 2961 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2021 | 2984 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6895 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 7793 | 0.080 |
Why?
|
Cell Line | 1 | 2021 | 15993 | 0.070 |
Why?
|
Prognosis | 3 | 2023 | 29052 | 0.070 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11036 | 0.070 |
Why?
|
Alleles | 1 | 2017 | 6934 | 0.070 |
Why?
|
Transcription Factors | 3 | 2022 | 12209 | 0.070 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9440 | 0.070 |
Why?
|
Immunotherapy | 1 | 2021 | 4437 | 0.060 |
Why?
|
Female | 8 | 2023 | 380020 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6535 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4839 | 0.060 |
Why?
|
Pregnancy | 1 | 2022 | 29140 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 379 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.040 |
Why?
|
Mutation | 1 | 2022 | 29777 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15518 | 0.040 |
Why?
|
Microarray Analysis | 1 | 2020 | 765 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1613 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2022 | 2419 | 0.030 |
Why?
|
Child | 1 | 2020 | 77637 | 0.030 |
Why?
|
Male | 2 | 2020 | 349776 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 72252 | 0.020 |
Why?
|
Adult | 1 | 2020 | 213889 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 16674 | 0.020 |
Why?
|